IBM sells 500 patents; Big four unite against open source NPE threat; Don’t bet on UPC breakthrough; Apple talks FRAND strategy; Time to rethink EPO oppositions; plus much more
Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week
MONDAY 18th November
TCL unit secures Shenzhen injunction against domestic rival Chongqing HKC in latest sign that China’s display panel patent war is intensifying. Read more here
South Africa's top court issues first patent decision but fails to clarify infringement defence uncertainties. Read more here
What started largely as a patent spat is set to become a software industry blockbuster after the Supreme Court granted cert late last week in Google v Oracle. Read more here
TUESDAY 19th November
AliBaba is due to price its Hong Kong secondary listing this week. Five years after its NYSE debut, the company has a more formidable patent portfolio and new IP-based alliances. Read more here
Opposition strategies at the EPO may need to be recalibrated in light of new evidence that the office is dealing with proceedings much more quickly than before. Read more here
IBM, Microsoft, the Linux Foundation and OIN join forces to counter perceived open source threat from NPEs. Read more here
WEDNESDAY 20th November
Goldpeak Innovations, a South Korean NPE created to monetise former Pantech patents, is back on the transactions radar with an apparent sale to Samsung Electronics. Read more here
Microsoft and Intel are providing the keynotes at the inaugural Data Business Congress, with senior leaders from a wide range of companies confirmed for the speaking faculty. Read more here
Senior players with backgrounds at IV, Kudelski and Lenovo, among others, have $10 million in hand and a plan to clear patent risk in the video sector. Read more here
THURSDAY 21st November
At IPBC Australasia in Melbourne, patent owners say more guidance from the patent office would be welcome after courts declined to clarify eligibility rules in a recent decision. Read more here
Several leading Democratic presidential candidates are threatening to circumvent pharma IP, so next year’s election could prove pivotal for life sciences patent owners. Read more here
With Intel deal set to close, and as courts around the world continue to weigh in on standards debate, Apple stakes out its position on SEPs and FRAND. Read more here
FRIDAY 22nd November
Three key IP dynamics facing automakers in Asia as they prepare for the Auto IP Asia conference in Shanghai next month. Read more here
Despite possible German Constitutional Court breakthrough, don't bet on the UPC's fate becoming clearer any time soon. Read more here
IBM’s big patent sell off continues with divestment of 500 assets, but its latest deal is not with an operating company. Read more here
SATURDAY 23rd November
It’s welcome that more rights owners than ever before are banding together to remedy patent market problems, but it may lead in an all-too-familiar direction. Read more here